• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌中、、、和基因的mRNA表达与甲基化

mRNA Expression and Methylation of the , , , , and Genes in Gastric Adenocarcinoma.

作者信息

Pádua Joel Del Bel, Mariano Carolline Fontes Alves, Fabro Alexandre Todorovic, Lizarte Neto Fermino Sanches, Zuliani Rogério Lenotti, Sares Cláudia Tarcila Gomes, Dos Santos José Sebastião, Sankarankutty Ajith Kumar, Tirapelli Daniela Pretti da Cunha, Silveira Vanessa da Silva, de Molfetta Greice Andreotti, Júnior Wilson Araújo da Silva, Brunaldi Mariângela Ottoboni

机构信息

Department of Pathology and Forensic Medicine, Ribeirão Preto Medical School, Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil.

Department of Surgery and Anatomy, Ribeirão Preto Medical School, USP, Ribeirão Preto, SP, Brazil.

出版信息

Biomark Insights. 2024 Jan 29;19:11772719231225206. doi: 10.1177/11772719231225206. eCollection 2024.

DOI:10.1177/11772719231225206
PMID:38293680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10826385/
Abstract

BACKGROUND

Immunohistochemical prognostic significance of the homologous recombination-related proteins RAD51, ATM, BRCA1, and BRCA2 is known in gastric adenocarcinoma, one of the deadliest cancers.

OBJECTIVE AND DESIGN

This retrospective cohort study aimed to evaluate mRNA expression and promoter methylation of some homologous recombination-related genes in this neoplasm.

METHODS

We evaluated mRNA expression and methylation of , , , , and in tumor and non-tumor frozen samples from gastrectomy specimens by RT-qPCR and MS-HRM, correlating our results with previous immunohistochemistry data and prognostic features.

RESULTS

, , , , and mRNA expression was detected in 93.75% (45/48), 93.75% (45/48), 91.67% (44/48), 83.33% (40/48), and 89.58% (43/48) of the tumors; partial or complete methylation, in 94.87% (37/39), 0 (0/42), 97.56% (40/41), 100% (41/41), and 0 (0/40), respectively. Most gene pairs showed significant weak to moderate positive correlations of tumoral mRNA expression with each other: with ( = .027), ( < .001), and ( < .001); with ( = .007), and ( = .001); with ( = 0.001). mRNA was reduced in tumors compared with non-neoplastic mucosa (0.345 vs 1.272,  = .015) and, excluding neoadjuvant therapy cases, in T3 to T4 tumors compared with T2 (0.414 vs 0.954,  = .035). Greater tumoral mRNA levels correlated with perineural invasion (1.822 vs 0.725,  = .010) and death (1.664 vs 0.929,  = .036), but not with survival time. There was an inverse association between nuclear immunohistochemical positivity for ATR and its mRNA levels (0.487 vs 0.907,  = .032), and no significant correlation for the other markers.

CONCLUSIONS

Our results suggest , , and methylation as a frequent epigenetic mechanism in gastric cancer, support the hypothesis that reduced expression participates in disease progression, and show an association between mRNA and perineural invasion and mortality that may be considered unexpected, considering the former immunohistochemical studies. The lack of correlation between immunohistochemistry and mRNA, and even the inverse association, for , can be seen as indicative of action of post-transcriptional or post-translational regulatory mechanisms, to be better investigated.

摘要

背景

同源重组相关蛋白RAD51、ATM、BRCA1和BRCA2的免疫组化预后意义在胃癌(最致命的癌症之一)中是已知的。

目的与设计

这项回顾性队列研究旨在评估该肿瘤中一些同源重组相关基因的mRNA表达和启动子甲基化情况。

方法

我们通过RT-qPCR和MS-HRM评估了胃癌切除标本中肿瘤和非肿瘤冷冻样本中、、、和的mRNA表达和甲基化情况,并将我们的结果与先前的免疫组化数据和预后特征相关联。

结果

在93.75%(45/48)、93.75%(45/48)、91.67%(44/48)、83.33%(40/48)和89.58%(43/48)的肿瘤中检测到、、、和的mRNA表达;部分或完全甲基化分别为94.87%(37/39)、0(0/42)、97.56%(40/41)、100%(41/41)和0(0/40)。大多数基因对显示肿瘤mRNA表达之间存在显著的弱至中度正相关:与(=0.027)、(<0.001)和(<0.001);与(=0.007)和(=0.001);与(=0.001)。与非肿瘤黏膜相比,肿瘤中的mRNA减少(0.345对1.272,=0.015),并且排除新辅助治疗病例后,与T2期肿瘤相比,T3至T4期肿瘤中的mRNA减少(0.414对0.954,=0.035)。更高的肿瘤mRNA水平与神经周围浸润(1.822对0.725,=0.010)和死亡(1.664对0.929,=0.036)相关,但与生存时间无关。ATR核免疫组化阳性与其mRNA水平之间存在负相关(0.487对0.907,=0.032),而其他标志物无显著相关性。

结论

我们的结果表明、和甲基化是胃癌中常见的表观遗传机制,支持表达降低参与疾病进展的假设,并显示mRNA与神经周围浸润和死亡率之间的关联,考虑到先前的免疫组化研究,这可能被认为是出乎意料的。、免疫组化与mRNA之间缺乏相关性,甚至存在负相关,可以被视为转录后或翻译后调控机制作用的指标,有待进一步深入研究。

相似文献

1
mRNA Expression and Methylation of the , , , , and Genes in Gastric Adenocarcinoma.胃癌中、、、和基因的mRNA表达与甲基化
Biomark Insights. 2024 Jan 29;19:11772719231225206. doi: 10.1177/11772719231225206. eCollection 2024.
2
Prognostic Value of the Immunohistochemical Expression of RAD51 and BRCA2 in Gastric Adenocarcinoma.胃腺癌中 RAD51 和 BRCA2 的免疫组化表达的预后价值。
J Histochem Cytochem. 2022 Mar;70(3):199-210. doi: 10.1369/00221554211065834. Epub 2022 Jan 3.
3
Simultaneous ATM/BRCA1/RAD51 expression variations associated with prognostic factors in Iranian sporadic breast cancer patients.伊朗散发性乳腺癌患者中与预后因素相关的ATM/BRCA1/RAD51表达同时变化。
Breast Cancer. 2017 Jul;24(4):624-634. doi: 10.1007/s12282-016-0750-z. Epub 2017 Jan 5.
4
Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells.人前列腺癌细胞中BRCA1、BRCA2、p300和Rad51表达的协调改变对基因毒性及其他应激的响应
Prostate. 1999 Jun 15;40(1):37-49. doi: 10.1002/(sici)1097-0045(19990615)40:1<37::aid-pros5>3.0.co;2-p.
5
Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma.BRCA1 表达缺失导致胃癌患者的生存状况恶化。
World J Gastroenterol. 2013 Mar 28;19(12):1968-74. doi: 10.3748/wjg.v19.i12.1968.
6
Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors.家族性乳腺癌中DNA修复蛋白的免疫组化表达可区分BRCA2相关肿瘤。
J Clin Oncol. 2005 Oct 20;23(30):7503-11. doi: 10.1200/JCO.2005.01.3698.
7
The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer.BRCA1/BRCA2/Rad51复合物是早期乳腺癌的一个预后和预测因素。
Radiother Oncol. 2007 Sep;84(3):242-51. doi: 10.1016/j.radonc.2007.06.012. Epub 2007 Aug 17.
8
expression and DNA homologous recombination repair factors in lung cancers with a high-grade fetal adenocarcinoma component.具有高级别胎儿腺癌成分的肺癌中的表达及DNA同源重组修复因子
Transl Lung Cancer Res. 2023 Aug 30;12(8):1738-1751. doi: 10.21037/tlcr-23-137. Epub 2023 Aug 16.
9
A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers.RAD51基因中的单核苷酸多态性会改变BRCA2携带者患乳腺癌的风险,但不会改变BRCA1携带者或非携带者患乳腺癌的风险。
Br J Cancer. 2004 May 17;90(10):2002-5. doi: 10.1038/sj.bjc.6601837.
10
Expression of DNA Damage Response Proteins and Associations with Clinicopathologic Characteristics in Chinese Familial Breast Cancer Patients with Mutations.中国携带突变的家族性乳腺癌患者中DNA损伤反应蛋白的表达及其与临床病理特征的关联
J Breast Cancer. 2018 Sep;21(3):297-305. doi: 10.4048/jbc.2018.21.e38. Epub 2018 Sep 12.

引用本文的文献

1
ATR-CHK1 Axis Inhibitors in Gastric Cancer Treatment.ATR-CHK1轴抑制剂在胃癌治疗中的应用
Int J Mol Sci. 2025 Aug 9;26(16):7709. doi: 10.3390/ijms26167709.
2
Association of DNA damage response pathway genes with rheumatoid arthritis risks: a case-control study.DNA损伤反应通路基因与类风湿关节炎风险的关联:一项病例对照研究。
Sci Rep. 2025 Jul 1;15(1):20937. doi: 10.1038/s41598-025-06656-9.

本文引用的文献

1
Expression and Prognostic Value of in Adenocarcinoma at the Gastroesophageal Junction.贲门腺癌中 的表达及预后价值 (原文中“Expression and Prognostic Value of in Adenocarcinoma at the Gastroesophageal Junction.”有缺失内容,翻译只能根据现有内容进行)
Iran J Public Health. 2022 Oct;51(10):2231-2243. doi: 10.18502/ijph.v51i10.10981.
2
The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study.2020 - 2040年185个国家胃癌的当前及未来发病率和死亡率:一项基于人群的建模研究
EClinicalMedicine. 2022 Apr 21;47:101404. doi: 10.1016/j.eclinm.2022.101404. eCollection 2022 May.
3
DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer.
DNA甲基化:胃癌的重要生物标志物和治疗靶点
Front Genet. 2022 Mar 4;13:823905. doi: 10.3389/fgene.2022.823905. eCollection 2022.
4
Prognostic Value of the Immunohistochemical Expression of RAD51 and BRCA2 in Gastric Adenocarcinoma.胃腺癌中 RAD51 和 BRCA2 的免疫组化表达的预后价值。
J Histochem Cytochem. 2022 Mar;70(3):199-210. doi: 10.1369/00221554211065834. Epub 2022 Jan 3.
5
Regulation of RAD51 at the Transcriptional and Functional Levels: What Prospects for Cancer Therapy?RAD51在转录水平和功能水平的调控:癌症治疗有哪些前景?
Cancers (Basel). 2021 Jun 11;13(12):2930. doi: 10.3390/cancers13122930.
6
Interferon regulatory factor-1 suppresses DNA damage response and reverses chemotherapy resistance by downregulating the expression of RAD51 in gastric cancer.干扰素调节因子-1通过下调胃癌中RAD51的表达来抑制DNA损伤反应并逆转化疗耐药性。
Am J Cancer Res. 2020 Apr 1;10(4):1255-1270. eCollection 2020.
7
Methylation profiling in promoter sequences of and ( ) genes in blood and cfDNA from women with impalpable breast lesions.不可触及乳腺病变女性血液和循环游离DNA中()基因启动子序列的甲基化分析。 (注:原文括号部分内容缺失,这里只能按原样翻译)
Oncol Lett. 2020 Apr;19(4):3003-3010. doi: 10.3892/ol.2020.11382. Epub 2020 Feb 10.
8
Clinical significance of BRCA1 and BRCA2 mRNA and protein expression in patients with sporadic gastric cancer.散发性胃癌患者中BRCA1和BRCA2 mRNA及蛋白表达的临床意义
Oncol Lett. 2019 May;17(5):4383-4392. doi: 10.3892/ol.2019.10132. Epub 2019 Mar 8.
9
Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types.多种癌症类型中同源重组相关基因突变的患病率。
JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.17.00286. Epub 2018 Jul 23.
10
3F-Box protein 32 degrades ataxia telangiectasia and Rad3-related and regulates DNA damage response induced by gemcitabine in pancreatic cancer.3F-Box蛋白32降解共济失调毛细血管扩张症突变蛋白和Rad3相关蛋白,并调节吉西他滨诱导的胰腺癌DNA损伤反应。
Oncol Lett. 2018 Jun;15(6):8878-8884. doi: 10.3892/ol.2018.8367. Epub 2018 Mar 28.